KERYX BIOPHARMACEUTICALS (KERX) Covered Calls

KERYX BIOPHARMACEUTICALS covered calls Keryx Biopharmaceuticals, Inc. is a biopharmaceutical Company, focusing on the acquisition, development & commercialization of novel pharmaceutical products for the treatment of life-threatening diseases, including renal disease & cancer.

You can sell covered calls on KERYX BIOPHARMACEUTICALS to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for KERX (prices last updated Mon 12:25 PM ET):

KERYX BIOPHARMACEUTICALS (KERX) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
3.05 -0.19 3.04 3.05 577K - 0.4B
Covered Calls For KERYX BIOPHARMACEUTICALS (KERX)
Expiration Strike Call Bid Net Debit Return
If Flat
Annualized
Return If Flat
Nov 16 3 0.00 3.05 -1.6% -116.8%
Dec 21 3 0.05 3.00 0.0% 0.0%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial


Extended Business Description

Keryx Biopharmaceuticals, Inc. is a biopharmaceutical company. It engages in the acquisition, development and commercialization of pharmaceutical products for the treatment of renal disease. It develops Zerenex, an oral, ferric iron-based compound that has the capacity to bind to phosphate in the gastrointestinal tract and form non-absorbable complexes. The company was founded in October 1998 and is headquartered in New York, NY.